World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
60
Citations
14777
World Ranking
3806
National Ranking
330

Overview

Dieter Schmidt was affiliated with Freie Universität Berlin in Germany. Their research centered on Medicine, with a particular focus on Critical Care and Intensive Care Medicine, Cardiology and Cardiovascular Medicine, and Anesthesiology and Pain Medicine.

The scientist's work covered topics including:

  • Intensive Care Unit Cognitive Disorders
  • Cardiac, Anesthesia and Surgical Outcomes
  • Anesthesia and Sedative Agents

Their recent publications included:

  • Quality contract 'prevention of postoperative delirium in the care of elderly patients' study protocol: a non-randomised, pre-post, monocentric, prospective trial (2023, BMJ Open)
  • Correspondence (2022, Deutsches Ärzteblatt international)

Dieter Schmidt frequently collaborated with other researchers, including:

  • Fatima Yürek
  • Julian-Dominic Zimmermann
  • Elisa Weidner
  • Armin Hauß
  • Enrico Dähnert

Their publications appeared primarily in the venues BMJ Open and Deutsches Ärzteblatt international.

Best Publications

  • Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

    Wolfgang Löscher;Dieter Schmidt

  • New avenues for anti-epileptic drug discovery and development

    Wolfgang Löscher;Henrik Klitgaard;Roy E. Twyman;Dieter Schmidt

  • Drug resistance in epilepsy : Putative neurobiologic and clinical mechanisms

    Dieter Schmidt;Wolfgang Löscher

  • Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.

    Wolfgang Löscher;Dieter Schmidt

  • Anxiety in patients with epilepsy: systematic review and suggestions for clinical management.

    Stefan Beyenburg;Alex J. Mitchell;Dieter Schmidt;Christian E. Elger

  • Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study

    Matti Sillanpää;Dieter Schmidt

  • Enzyme induction with antiepileptic drugs: Cause for concern?

    Martin J. Brodie;Scott Mintzer;Alison M. Pack;Barry E. Gidal

  • Drug treatment of epilepsy in adults

    Dieter Schmidt;Steven C Schachter

  • The clinical impact of pharmacogenetics on the treatment of epilepsy

    Wolfgang Löscher;Ulrich Klotz;Fritz Zimprich;Dieter Schmidt

  • Double-Blind, Placebo-Controlled Trial of Topiramate as Add-on Therapy in Patients with Refractory Partial Seizures

    Elinor Ben-Menachem;Olaf Henriksen;Mogens Dam;Marianne Mikkelsen

  • Modern management of epilepsy: a practical approach.

    Christian E. Elger;Dieter Schmidt

  • Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

    Wolfgang Löscher;Dieter Schmidt

  • Experimental and Clinical Evidence for Loss of Effect (Tolerance) during Prolonged Treatment with Antiepileptic Drugs

    Wolfgang Löscher;Dieter Schmidt

  • Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.

    Herm J Lamberink;Willem M Otte;Ada T Geerts;Milen Pavlovic

  • Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

    Pavel Klein;Raymond Dingledine;Eleonora Aronica;Christophe Bernard

  • What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs

    Dieter Schmidt;Christian E. Elger

  • Drug treatment of epilepsy: options and limitations.

    Dieter Schmidt

  • Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience.

    Dieter Schmidt;Christoph Baumgartner;Wolfgang Löscher

  • Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy

    Matti Sillanpää;Dieter Schmidt

  • Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.

    Stefan Beyenburg;Knut Stavem;Knut Stavem;Dieter Schmidt

  • Report of the ILAE Commission on Antiepileptic Drugs : Considerations on Designing Clinical Trials to Evaluate the Place of New Antiepileptic Drugs in the Treatment of Newly Diagnosed and Chronic Patients with Epilepsy

    D. Chadwick;E. Beghi;N. Callaghan;P. de Bittencourt

  • Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician.

    D Schmidt;L Gram;M Brodie;G Krämer

Frequent Co-Authors

Christian E. Elger
Christian E. Elger University Hospital Bonn
Wolfgang Löscher
Wolfgang Löscher University of Veterinary Medicine Hannover, Foundation
Aristea S. Galanopoulou
Aristea S. Galanopoulou Albert Einstein College of Medicine
Steven C. Schachter
Steven C. Schachter Beth Israel Deaconess Medical Center
Alexis Arzimanoglou
Alexis Arzimanoglou Hospital Sant Joan de Déu Barcelona
Bernhard J. Steinhoff
Bernhard J. Steinhoff University of Göttingen
Soheyl Noachtar
Soheyl Noachtar Ludwig-Maximilians-Universität München
Bettina Schmitz
Bettina Schmitz Charité - University Medicine Berlin
Eugen Trinka
Eugen Trinka Paracelsus Medical University
Amy R. Brooks-Kayal
Amy R. Brooks-Kayal University of Colorado Denver

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Dieter Schmidt